Search Results 561-570 of 18083 for monoclonal antibody

  1. Hematology - Clinical trials

    ... monoclonal antibody, and compare them with clinical outcomes. A Study to ... The purpose of this study is to evaluate the immune and hematopoietic compartments in ...

  2. A Study To Compare Three Chemotherapy Regimens For The Treatment Of Patients With Newly- Diagnosed Mantle Cell Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Acalabrutinib may stop the growth of cancer ...

  3. Medical Research & Education - Mayo Clinic News Network

    Monoclonal antibody treatment can help high-risk patients with COVID-19 featured image. Featured News. Monoclonal antibody treatment can help high-risk ...

  4. Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find ...

  5. Study Of Rituximab And LMP-Specific T-Cells In Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder - Mayo Clinic

    Monoclonal antibodies, such as rituximab may block tumor growth in different ways by targeting certain cells. LMP-specific T-cells are special immune system ...

  6. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...

  7. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  8. Ide-cel, a BCMA-directed CAR-T cell therapy, shows favorable risk-benefit profile and response - Mayo Clinic

    ... monoclonal antibodies. The dose escalation phase of the study (50, 140, 450 and 800 x 106 total fixed doses of CAR -T cells) involved 21 patients; in the ...

  9. Hematology - Clinical trials

    ... monoclonal antibody, and compare them with clinical outcomes. A Study to Evaluate Immune and Hematopoietic Cell Assessment in Clonal B Cell Conditions.

  10. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...